Microba Life Sciences

We're #hiring a new Data Scientist (Bioinformatics) in Brisbane, Queensland. Apply today or share this post with your network.

We're #hiring a new Clinical Microbiologist (Pathogen Genomics) in Brisbane City, Queensland. Apply today or share this post with your network.

Microba is pleased to share a summary of its activities for the quarter ended 30 September 2024. See here for the full Quarterly Investor Video Presentation: https://loom.ly/B0xheUA See here for the full Quarterly Activities Report: https://loom.ly/Nlpdkj8 Commenting on the quarter, Dr Luke Reid, Microba CEO said, “Microba is intensively focused on executing its testing and therapeutic business strategies. This quarter’s continued strong results demonstrate the traction we are gaining in the market, giving us great confidence and excitement for the growth ahead.” For more Company information and to engage with management by asking questions about Microba’s latest announcements and updates, visit: https://loom.ly/om8m1_s

We're #hiring a new Lead Specialist (Remote) in Australia. Apply today or share this post with your network.

We're #hiring a new Medical Sales Specialist in Sydney, New South Wales. Apply today or share this post with your network.

We're #hiring a new Medical Sales Specialist (Lead) - Sydney NSW in Sydney, New South Wales. Apply today or share this post with your network.

Today is the ASX Small and Mid-Cap Conference in Sydney, have you registered to watch our presentation either in-person or virtually online? Microba CEO Dr. Luke Reid will be presenting live at 11.40 am. Microba will also host a stand at the conference, allowing current and prospective shareholders to meet and speak about Microba with CEO Dr. Luke Reid and CFO Mr. James Heath. Register: https://loom.ly/QZRnQM4 #ASXMID

Microba’s CEO, Dr Luke Reid, will be presenting at the ASX Small & Mid-Cap Conference this Wednesday, 25 September, at 11:40 am at the ASX office in Sydney. Join Dr. Reid as he discusses Microba’s key activities and developments across its diagnostics and therapeutics business units. You can also livestream our presentation online via the ASX conference platform or watch the recording on our Investor Hub after the conference has concluded. You can register to attend the conference in-person or online via the link below. We look forward to seeing you in Sydney! Register: https://loom.ly/QZRnQM4 #ASXMID

Microba is pleased to release the Group’s Annual Report & Appendix 4E for the year ended 30 June 2024. "We remain steadfast in our belief that the human gut microbiome represents one of the biggest untapped opportunities to improve human health, and that microbiome testing and therapeutics will become a routine part of healthcare. After many years of dedicated effort, we are witnessing the realisation of this vision." Read the full report here: https://loom.ly/KHDjXcA

Microba is proud to welcome Eric Davis as Microba’s Chief Growth Officer. Eric brings a wealth of experience in global commercial leadership roles across strategic planning, new product innovation, as well as consumer and professional marketing. Eric has led high-performance teams at Cochlear, as well as at multiple divisions in Abbott, driving numerous global product launches and significant revenue growth. Eric is a graduate of Harvard College and the Healthcare Management MBA program at the University of Pennyslvania's Wharton School of Business. Eric will spearhead the next phase of Microba’s medical diagnostics go-to-market strategy and growth. Eric Davis, Microba's Chief Growth Officer said, “I feel very lucky to join such a vibrant and exciting company with a strong and aligned leadership team, strong IP and a strong financial position, and I look forward to driving the growth of this important emerging diagnostic category around the world.”